share_log

广济药业:《湖北广化制药有限公司审计报告》(2023年)大信审字[2024]第2-00441号

Guangji Pharmaceutical: “Hubei Guanghua Pharmaceutical Co., Ltd. Audit Report” (2023) Daxin Review [2024] No. 2-00441

SZSI ·  Dec 28, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more